US Stock MarketDetailed Quotes

FENC Fennec Pharmaceuticals

Watchlist
  • 7.190
  • +0.070+0.98%
Close May 22 16:00 ET
196.45MMarket Cap179.75P/E (TTM)

Fennec Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
800.14%39.05M
5.07%-17.14M
28.55%-4.86M
44.91%-2.76M
-16.40%-3.95M
-95.27%-5.58M
-26.97%-18.06M
-109.61%-6.8M
-69.37%-5.01M
23.41%-3.39M
Net income from continuing operations
312.11%12.84M
32.34%-16.05M
60.89%-2.68M
76.92%-1.87M
-7.33%-5.44M
-63.74%-6.05M
-36.71%-23.71M
-54.89%-6.86M
-93.29%-8.09M
-26.77%-5.07M
Depreciation and amortization
1,290.38%723K
----
----
----
----
--52K
----
----
----
----
Other non cash items
1,990.00%418K
1.77%287K
-30.00%70K
-26.53%72K
190.70%125K
-51.22%20K
0.00%282K
-62.26%100K
1,125.00%98K
--43K
Change In working capital
3,433.38%23.87M
-714.51%-6.78M
-233.44%-3.1M
-267.39%-1.84M
-279.45%-1.12M
-331.72%-716K
218.35%1.1M
-467.07%-930K
222.87%1.1M
133.95%623K
-Change in receivables
-957.97%-1.46M
-370.49%-7.27M
-177.61%-4.29M
---2.08M
---762K
---138K
---1.55M
---1.55M
--0
--0
-Change in inventory
126.90%92K
-174.31%-1.58M
30.38%-401K
---316K
---521K
---342K
---576K
---576K
--0
--0
-Change in prepaid assets
-1,560.31%-1.91M
-60.61%104K
14.84%-419K
-0.94%210K
-19.11%182K
-58.93%131K
211.39%264K
-348.48%-492K
125.76%212K
7.14%225K
-Change in payables and accrued expense
654.50%2.04M
-33.51%1.96M
19.27%2.01M
-61.46%343K
-104.24%-17K
-1,938.89%-367K
526.26%2.95M
566.94%1.68M
-23.67%890K
119.62%401K
-Change in other current assets
---133K
-50.00%3K
50.00%3K
--0
--0
--0
400.00%6K
200.00%2K
50.00%-1K
-200.00%-3K
-Change in other current liabilities
--25.25M
----
----
----
----
--0
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
800.14%39.05M
5.07%-17.14M
28.55%-4.86M
44.91%-2.76M
-16.40%-3.95M
-95.27%-5.58M
-26.97%-18.06M
-109.61%-6.8M
-69.37%-5.01M
23.41%-3.39M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-686.53%-1.13M
-67.98%6.64M
595.39%5.73M
-98.99%201K
1,017.39%514K
1,186.67%193K
316.47%20.73M
8,140.00%824K
19.85M
-99.07%46K
Net issuance payments of debt
----
-74.93%5M
7,787.69%5M
----
----
----
298.70%19.94M
---65K
----
----
Proceeds from stock option exercised by employees
194.37%627K
84.91%1.72M
10.01%747K
14.36%215K
1,076.09%541K
1,320.00%213K
2,712.12%928K
7,444.44%679K
--188K
91.67%46K
Net other financing activities
-8,695.00%-1.76M
42.75%-75K
-106.67%-14K
---14K
---27K
---20K
-138.18%-131K
20,900.00%210K
----
----
Cash from discontinued financing activities
Financing cash flow
-686.53%-1.13M
-67.98%6.64M
595.39%5.73M
-98.99%201K
1,017.39%514K
1,186.67%193K
316.47%20.73M
8,140.00%824K
--19.85M
-99.07%46K
Net cash flow
Beginning cash position
-44.19%13.27M
12.67%23.77M
-58.33%12.4M
0.29%14.96M
0.72%18.39M
12.67%23.77M
-30.46%21.1M
22.26%29.75M
-45.35%14.92M
-31.74%18.26M
Current changes in cash
804.22%37.92M
-492.86%-10.51M
114.55%870K
-117.25%-2.56M
-2.63%-3.43M
-89.51%-5.38M
128.93%2.67M
-84.79%-5.98M
601.59%14.84M
-716.97%-3.34M
End cash Position
178.33%51.18M
-44.19%13.27M
-44.19%13.27M
-58.33%12.4M
0.29%14.96M
0.72%18.39M
12.67%23.77M
12.67%23.77M
22.26%29.75M
-45.35%14.92M
Free cash flow
800.14%39.05M
5.07%-17.14M
28.55%-4.86M
44.91%-2.76M
-16.40%-3.95M
-95.27%-5.58M
-26.97%-18.06M
-109.61%-6.8M
-69.37%-5.01M
23.41%-3.39M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 800.14%39.05M5.07%-17.14M28.55%-4.86M44.91%-2.76M-16.40%-3.95M-95.27%-5.58M-26.97%-18.06M-109.61%-6.8M-69.37%-5.01M23.41%-3.39M
Net income from continuing operations 312.11%12.84M32.34%-16.05M60.89%-2.68M76.92%-1.87M-7.33%-5.44M-63.74%-6.05M-36.71%-23.71M-54.89%-6.86M-93.29%-8.09M-26.77%-5.07M
Depreciation and amortization 1,290.38%723K------------------52K----------------
Other non cash items 1,990.00%418K1.77%287K-30.00%70K-26.53%72K190.70%125K-51.22%20K0.00%282K-62.26%100K1,125.00%98K--43K
Change In working capital 3,433.38%23.87M-714.51%-6.78M-233.44%-3.1M-267.39%-1.84M-279.45%-1.12M-331.72%-716K218.35%1.1M-467.07%-930K222.87%1.1M133.95%623K
-Change in receivables -957.97%-1.46M-370.49%-7.27M-177.61%-4.29M---2.08M---762K---138K---1.55M---1.55M--0--0
-Change in inventory 126.90%92K-174.31%-1.58M30.38%-401K---316K---521K---342K---576K---576K--0--0
-Change in prepaid assets -1,560.31%-1.91M-60.61%104K14.84%-419K-0.94%210K-19.11%182K-58.93%131K211.39%264K-348.48%-492K125.76%212K7.14%225K
-Change in payables and accrued expense 654.50%2.04M-33.51%1.96M19.27%2.01M-61.46%343K-104.24%-17K-1,938.89%-367K526.26%2.95M566.94%1.68M-23.67%890K119.62%401K
-Change in other current assets ---133K-50.00%3K50.00%3K--0--0--0400.00%6K200.00%2K50.00%-1K-200.00%-3K
-Change in other current liabilities --25.25M------------------0----------------
Cash from discontinued investing activities
Operating cash flow 800.14%39.05M5.07%-17.14M28.55%-4.86M44.91%-2.76M-16.40%-3.95M-95.27%-5.58M-26.97%-18.06M-109.61%-6.8M-69.37%-5.01M23.41%-3.39M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -686.53%-1.13M-67.98%6.64M595.39%5.73M-98.99%201K1,017.39%514K1,186.67%193K316.47%20.73M8,140.00%824K19.85M-99.07%46K
Net issuance payments of debt -----74.93%5M7,787.69%5M------------298.70%19.94M---65K--------
Proceeds from stock option exercised by employees 194.37%627K84.91%1.72M10.01%747K14.36%215K1,076.09%541K1,320.00%213K2,712.12%928K7,444.44%679K--188K91.67%46K
Net other financing activities -8,695.00%-1.76M42.75%-75K-106.67%-14K---14K---27K---20K-138.18%-131K20,900.00%210K--------
Cash from discontinued financing activities
Financing cash flow -686.53%-1.13M-67.98%6.64M595.39%5.73M-98.99%201K1,017.39%514K1,186.67%193K316.47%20.73M8,140.00%824K--19.85M-99.07%46K
Net cash flow
Beginning cash position -44.19%13.27M12.67%23.77M-58.33%12.4M0.29%14.96M0.72%18.39M12.67%23.77M-30.46%21.1M22.26%29.75M-45.35%14.92M-31.74%18.26M
Current changes in cash 804.22%37.92M-492.86%-10.51M114.55%870K-117.25%-2.56M-2.63%-3.43M-89.51%-5.38M128.93%2.67M-84.79%-5.98M601.59%14.84M-716.97%-3.34M
End cash Position 178.33%51.18M-44.19%13.27M-44.19%13.27M-58.33%12.4M0.29%14.96M0.72%18.39M12.67%23.77M12.67%23.77M22.26%29.75M-45.35%14.92M
Free cash flow 800.14%39.05M5.07%-17.14M28.55%-4.86M44.91%-2.76M-16.40%-3.95M-95.27%-5.58M-26.97%-18.06M-109.61%-6.8M-69.37%-5.01M23.41%-3.39M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg